Component

Human SARM1 TIR E642A construct

Catalytically impaired human SARM1 TIR-domain fragment bearing E642A.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What it acts on

  1. The human SARM1 TIR E642A mutant failed to cleave NAD+ in the cell-free NADase assay.

    Human SARM1 TIR E642A construct → NAD+ source_derived_draftungraded
    Experimental context and source evidence
    availability_state
    machinery_impairment Imported condition classification; unverified.
    cross_nutrient
    false
    evidence_span
    {"source_cache": "artifacts/niacin-consumption-sources/sarm2017.txt", "locator": "Full text, normalized paragraph 27", "start_char": 18354, "end_char": 20343, "file_sha256": "fc30de231911f5c30425173d684495e62c725ba27c78d44592e6bc68433ef545", "text_sha256": "eda6dc283d30b48f68dc8626f2ea00ffb36d08cf8597eb6e7b1ce7e091fd0cb3"}
    experimental_model
    Cell-free translation, purification and NADase assay
    exposure
    E642A compared with wild-type TIR
    limitations
    Purified engineered TIR fragment rather than basal activity of intact full-length SARM1; no dietary dose inference.
    nutrient_topic
    Niacin research collection; topical membership is not evidence of a direct dietary effect. · Niacin (vitamin B3)
    organism
    Human
    plain_language
    Changing a catalytic glutamate disabled NAD cleavage in the assay.
    primary_references
    [b3-cons-sarm2017] The SARM1 Toll/Interleukin-1 Receptor Domain Possesses Intrinsic NAD+ Cleavage Activity that Promotes Pathological Axonal Degeneration. (2017). https://pubmed.ncbi.nlm.nih.gov/28334607/ DOI: 10.1016/j.neuron.2017.02.022
    tissue_or_cell_type
    Purified human mutant domain
    trigger_kind
    machinery_impairment Imported condition classification; unverified.

    Niacin: NAD metabolism, deficiency and nutrient interactions (2026-09-17) · lines 719–731

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Cell-free translation, purification and NADase assay · source_derived_draft · unverified_draft

    ### b3-cons-sarm-e642a-loss The human SARM1 TIR E642A mutant failed to cleave NAD+ in the cell-free NADase assay. Condition category: machinery_impairment nutrient_topic: Niacin research collection; topical membership is not evidence of a direct dietary effect. plain_language: Changing a catalytic glutamate disabled NAD cleavage in the assay. organism: Human tissue_or_cell_type: Purified human mutant domain experimental_model: Cell-free translation, purification and NADase assay limitations: Purified engineered TIR fragment rather than basal activity of intact full-length SARM1; no dietary dose inference. exposure: E642A compared with wild-type TIR cross_nutrient: false evidence_span: {"source_cache": "artifacts/niacin-consumption-sources/sarm2017.txt", "locator": "Full text, normalized paragraph 27", "start_char": 18354, "end_char": 20343, "file_sha256": "fc30de231911f5c30425173d684495e62c725ba27c78d44592e6bc68433ef545", "text_sha256": "eda6dc283d30b48f68dc8626f2ea00ffb36d08cf8597eb6e7b1ce7e091fd0cb3"} [b3-cons-sarm2017] The SARM1 Toll/Interleukin-1 Receptor Domain Possesses Intrinsic NAD+ Cleavage Activity that Promotes Pathological Axonal Degeneration. (2017). https://pubmed.ncbi.nlm.nih.gov/28334607/ DOI: 10.1016/j.neuron.2017.02.022
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards